Additional Proxy Soliciting Materials (definitive) (defa14a)
October 12 2021 - 5:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Pursuant to §240.14a-12
|
BIOLASE,
INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing Party:
|
|
|
(4)
|
|
Date Filed:
|
BIOLASE, Inc. (the Company) has posted materials to its website in connection with the
Companys special meeting of stockholders to be held on November 19, 2021. A copy of the materials posted to the website can be found below.
A special meeting of stockholders (the Special Meeting) of BIOLASE, Inc., a Delaware corporation
(the Company, we, us or our), will be held on November 19, 2021, at 10:00 a.m. Pacific Time at the Companys corporate headquarters,
located at 27042 Towne Centre Drive, Suite 270, Foothill Ranch, California 92610. At the Special Meeting, stockholders will be asked to vote on the following matters, as more fully described in the proxy materials:
1.
|
the approval of an amendment to the Companys Certificate of Incorporation to effect a reverse stock split
of Company common stock (without reducing the authorized number of shares of Company common stock), if and when determined by the Companys board of directors (the Amendment Proposal);
|
2.
|
to approve the adjournment of the Special Meeting, if necessary, in the reasonable discretion of the Chief
Executive Officer and President of the Company, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Amendment Proposal (the Adjournment Proposal); and
|
3.
|
to transact other such business as may properly come before the Special Meeting or any adjournment or
postponement thereof.
|
Our Board of Directors unanimously recommends that our stockholders vote FOR the
Amendment Proposal and the Adjournment Proposal. Stockholders of record at the close of business on October 1, 2021 are entitled to notice of and to vote at the Special Meeting and any adjournment or postponement thereof. All stockholders are
cordially invited to attend the Special Meeting in person.
Whether or not you plan to attend the Special Meeting, please vote as promptly
as possible.
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From Apr 2023 to Apr 2024